{"filing":{"accession_number":"0001906324-26-000028","cik":"0001906324","ticker":"QDEL","company_name":"QuidelOrtho Corp","form":"8-K","filing_date":"2026-06-23","report_date":null,"primary_document":"qdel-20260622.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1906324/000190632426000028/qdel-20260622.htm"},"events":[{"id":13138,"run_id":11661,"accession_number":"0001906324-26-000028","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"QuidelOrtho appointed Micah Young as Chief Financial Officer effective July 6, 2026, succeeding retiring CFO Joseph M. Busky. Young brings extensive experience from Masimo, NuVasive, and Zimmer Holdings, with a compensation package including a $750,000 base salary, $500,000 sign-on bonus, $6.5M inducement RSU grant, and $5M expected 2027 equity grant.","company_name":"QuidelOrtho Corp","ticker":"QDEL","filing_date":"2026-06-23","form":"8-K","submitted_at":null,"items":[{"id":10201,"accession_number":"0001906324-26-000028","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Micah Young as Chief Financial Officer effective July 6, 2026, succeeding Joseph M. Busky. While the section also addresses Busky's departure and transition arrangements, the principal disclosed action centers on Young's appointment to a named executive officer role. The detailed compensation terms ($750,000 base salary, $500,000 sign-on bonus, $6.5M inducement RSU grant, and $5M expected 2027 equity grant) and his extensive background at Masimo, NuVasive, and Zimmer Holdings establish this as a material executive appointment affecting the company's financial leadership.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-23T20:05:49.009619+00:00","company_name":"","ticker":null,"filing_date":""},{"id":10202,"accession_number":"0001906324-26-000028","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing announces the appointment of Micah Young as Chief Financial Officer of QuidelOrtho, effective July 6, 2026, succeeding retiring CFO Joseph M. Busky. This is a material executive appointment of a named executive officer to a C-suite position. The press release emphasizes Young's extensive experience at major medical technology companies (Masimo, NuVasive, Zimmer) and his track record in financial performance and capital allocation, making this a significant leadership transition that would affect investor assessment of the company's financial management.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-23T20:05:49.009619+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":10201,"accession_number":"0001906324-26-000028","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Micah Young as Chief Financial Officer effective July 6, 2026, succeeding Joseph M. Busky. While the section also addresses Busky's departure and transition arrangements, the principal disclosed action centers on Young's appointment to a named executive officer role. The detailed compensation terms ($750,000 base salary, $500,000 sign-on bonus, $6.5M inducement RSU grant, and $5M expected 2027 equity grant) and his extensive background at Masimo, NuVasive, and Zimmer Holdings establish this as a material executive appointment affecting the company's financial leadership.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-23T20:05:49.009619+00:00","company_name":"QuidelOrtho Corp","ticker":"QDEL","filing_date":"2026-06-23"},{"id":10202,"accession_number":"0001906324-26-000028","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing announces the appointment of Micah Young as Chief Financial Officer of QuidelOrtho, effective July 6, 2026, succeeding retiring CFO Joseph M. Busky. This is a material executive appointment of a named executive officer to a C-suite position. The press release emphasizes Young's extensive experience at major medical technology companies (Masimo, NuVasive, Zimmer) and his track record in financial performance and capital allocation, making this a significant leadership transition that would affect investor assessment of the company's financial management.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-23T20:05:49.009619+00:00","company_name":"QuidelOrtho Corp","ticker":"QDEL","filing_date":"2026-06-23"}]}